BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18635722)

  • 1. A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder.
    Allgulander C; Nutt D; Detke M; Erickson J; Spann M; Walker D; Ball S; Russell J
    J Psychopharmacol; 2008 Jun; 22(4):417-25. PubMed ID: 18635722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial.
    Hartford J; Kornstein S; Liebowitz M; Pigott T; Russell J; Detke M; Walker D; Ball S; Dunayevich E; Dinkel J; Erickson J
    Int Clin Psychopharmacol; 2007 May; 22(3):167-74. PubMed ID: 17414743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial.
    Nicolini H; Bakish D; Duenas H; Spann M; Erickson J; Hallberg C; Ball S; Sagman D; Russell JM
    Psychol Med; 2009 Feb; 39(2):267-76. PubMed ID: 18485261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishing non-inferiority in treatment trials in psychiatry: guidelines from an Expert Consensus Meeting.
    Nutt D; Allgulander C; Lecrubier Y; Peters T; Wittchen U
    J Psychopharmacol; 2008 Jun; 22(4):409-16. PubMed ID: 18635721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: a meta-analysis of randomized clinical trials.
    Vis PM; van Baardewijk M; Einarson TR
    Ann Pharmacother; 2005 Nov; 39(11):1798-807. PubMed ID: 16189284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.
    Montgomery SA; Sheehan DV; Meoni P; Haudiquet V; Hackett D
    J Psychiatr Res; 2002; 36(4):209-17. PubMed ID: 12191625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of gastrointestinal symptom severity on response to venlafaxine extended-release in patients with generalized anxiety disorder.
    Lydiard RB; Pitrosky B; Hackett D; White C
    J Clin Psychiatry; 2004 Jun; 65(6):838-44. PubMed ID: 15291662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A; Korotzer A; Gommoll C; Li D
    Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial.
    Alaka KJ; Noble W; Montejo A; DueƱas H; Munshi A; Strawn JR; Lenox-Smith A; Ahl J; Bidzan L; Dorn B; Ball S
    Int J Geriatr Psychiatry; 2014 Sep; 29(9):978-86. PubMed ID: 24644106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
    Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
    J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of pregabalin in the treatment of generalized anxiety disorder: a 6-week, multicenter, randomized, double-blind, placebo-controlled comparison of pregabalin and venlafaxine.
    Montgomery SA; Tobias K; Zornberg GL; Kasper S; Pande AC
    J Clin Psychiatry; 2006 May; 67(5):771-82. PubMed ID: 16841627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine: a review of its use in the treatment of generalized anxiety disorder.
    Carter NJ; McCormack PL
    CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.
    Rickels K; Etemad B; Khalid-Khan S; Lohoff FW; Rynn MA; Gallop RJ
    Arch Gen Psychiatry; 2010 Dec; 67(12):1274-81. PubMed ID: 21135327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
    Davidson JR; DuPont RL; Hedges D; Haskins JT
    J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.
    Silverstone PH; Salinas E
    J Clin Psychiatry; 2001 Jul; 62(7):523-9. PubMed ID: 11488362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
    Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
    JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind, placebo-controlled comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Gee MD; Krishen A; Wunderlich HP; Le Clus A; Evoniuk G; Modell JG
    J Psychopharmacol; 2010 Aug; 24(8):1209-16. PubMed ID: 19939870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
    Nimatoudis I; Zissis NP; Kogeorgos J; Theodoropoulou S; Vidalis A; Kaprinis G
    Int Clin Psychopharmacol; 2004 Nov; 19(6):331-6. PubMed ID: 15486518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A method for controlling for a high placebo response rate in a comparison of venlafaxine XR and diazepam in the short-term treatment of patients with generalised anxiety disorder.
    Hackett D; Haudiquet V; Salinas E
    Eur Psychiatry; 2003 Jun; 18(4):182-7. PubMed ID: 12814852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.